Fact-checked by Grok 2 weeks ago

Chromium trioxide


(CrO₃) is an comprising in the hexavalent bonded to three oxygen atoms, manifesting as a dark-purplish red to brown crystalline solid that functions as the acidic anhydride of . It exhibits strong oxidizing properties, decomposing to release toxic fumes when heated, and reacts vigorously with and organic materials. Industrially synthesized by adding concentrated to a of , prompting of the trioxide, this compound is chiefly employed in baths to deposit protective metallic coatings and as a in organic oxidations, such as converting alcohols to carbonyl compounds. However, its utility is overshadowed by profound hazards: it is acutely corrosive, causing severe burns on contact, and represents a confirmed human via or , primarily targeting the and inducing genotoxic and reproductive toxicities. Regulatory frameworks, including OSHA's of 5 µg/m³ for and EU REACH authorizations treating it as a , underscore stringent controls due to its non-threshold carcinogenic risk.

History

Discovery and early development

Chromium trioxide (CrO₃) was first prepared in 1797 by the French chemist Louis-Nicolas Vauquelin during his investigations into , a lead chromate mineral (PbCrO₄) sourced from . Vauquelin obtained the compound by reacting with , yielding CrO₃ alongside lead chloride precipitation. This synthesis represented the initial isolation of the acidic anhydride of , highlighting chromium's distinctive multicolored compounds that prompted its naming from the Greek (color). In 1798, Vauquelin advanced the compound's utility by reducing with at elevated temperatures, thereby isolating elemental metal for the first time—approximately 128 pm —and confirming its status as a novel . This reduction process underscored CrO₃'s role as a key intermediate in early chemistry, leveraging its high oxygen content for efficient metal recovery. Early development of chromium trioxide centered on its application in synthesizing chromates and dichromates, which Vauquelin produced by fusing with carbonates to form soluble salts like (K₂CrO₄). These derivatives enabled the creation of vibrant pigments for dyes and inks, capitalizing on chromium()'s intense yellow-to-orange hues, with initial commercial interest emerging in the early for and artistic media. By the 1820s, refined preparations involving acidification of dichromates began yielding purer CrO₃ crystals, facilitating analytical uses in qualitative chemistry and oxidation reactions, though handling risks from its strong oxidizing nature were noted contemporaneously.

Industrial adoption

Commercial production and use of chromium trioxide emerged in the early , driven by its role in formulating baths for . Initial experimental of dates to 1855, but practical, adherent deposits eluded researchers until advancements in bath chemistry using chromium trioxide with . In 1924, Colin G. Fink and Charles H. Eldridge developed a viable process at , building on George J. Sargent's 1920 studies of deposition from solutions derived from the trioxide, marking the onset of commercial . Adoption accelerated with the 1927 patent for hard by engineers employing trioxide-sulfuric acid electrolytes, which yielded durable, corrosion-resistant coatings for industrial machinery, tools, and automotive parts. This process supplanted less effective for wear applications, with U.S. production capacity reaching 36,000 tonnes annually by 1978 across two major facilities. By , decorative proliferated in automobile manufacturing for bright trim, boosting demand as vehicles incorporated finishes for aesthetic and protective qualities. Beyond , chromium trioxide saw limited early adoption in aluminum for layer formation and in leather tanning as a , though these applications trailed in scale. Its oxidizing properties also found niche use in and , but industrial dominance stemmed from plating's efficiency in enhancing metal and , with global output tied to sectors like and .

Chemical properties

Molecular structure and bonding

In the solid state, chromium trioxide (CrO₃) forms a polymeric consisting of infinite one-dimensional chains of corner-sharing CrO₄ tetrahedra, arranged in an orthorhombic lattice with Ama2. Each Cr⁶⁺ is tetrahedrally coordinated to four O²⁻ ions, where two oxygen atoms are terminal and two are bridging, linking adjacent tetrahedra along the chain direction parallel to the c-axis. This polymeric arrangement arises because the monomeric CrO₃ unit is unstable in isolation under standard conditions, preferring to achieve higher coordination and stability for the d⁰ Cr(VI) center. The Cr–O bond lengths reflect the bonding asymmetry: terminal Cr–O bonds measure approximately 1.56–1.60 Å, consistent with partial multiple-bond character involving Cr–O π interactions, while bridging Cr–O bonds are longer at about 1.76–1.80 Å, resembling single bonds. Density functional theory calculations on bulk-like models confirm this differentiation, with the short bonds attributed to the localization of electron density in Cr=O-like linkages and the longer ones to shared oxygen atoms between chromium centers. The overall bonding is polar covalent, dominated by σ-bonds from oxygen lone pairs to chromium empty orbitals, augmented by π-donation from oxygen to chromium, though the high formal oxidation state introduces some ionic contributions. In the gas phase or as an isolated , CrO₃ adopts a monomeric pyramidal with C_{3v} symmetry, featuring three equivalent Cr–O bonds of around 1.60 Å, as predicted by . This geometry contrasts with the planar D_{3h} form expected for simple trigonal molecules, arising from Jahn-Teller-like or avoidance of close oxygen repulsions in the d⁰ configuration. However, such monomers are not observed in the condensed phase, where prevails.

Physical characteristics

Chromium trioxide (CrO₃) is a dark red to brown crystalline solid, typically appearing as a or flakes. It is deliquescent, readily absorbing from the air. The compound has a of 2.7 g/cm³ at 20 °C. Its is 197 °C, after which it decomposes at approximately 250 °C without . In the solid state, chromium trioxide adopts a polymeric structure consisting of infinite chains of corner-sharing CrO₄ tetrahedra aligned parallel to the c-axis of the crystal lattice. Chromium trioxide exhibits high solubility in , dissolving at rates exceeding 160 g per 100 mL at temperatures around 25 °C, with dissolution being strongly exothermic and yielding acidic solutions due to forming . It is also soluble in , , acetic acid, and acetone.

Reactivity and stability

Chromium trioxide exhibits thermal instability above its melting point of 197 °C, at which point it begins to decompose into chromium(III) oxide and oxygen gas via the reaction $4 \mathrm{CrO_3} \rightarrow 2 \mathrm{Cr_2O_3} + 3 \mathrm{O_2}. Full decomposition occurs around 250 °C, liberating oxygen that can support combustion. Bulk CrO3 lacks long-term stability at elevated temperatures, transitioning through intermediate oxides before complete reduction. As a potent oxidizing agent, chromium trioxide reacts vigorously with reducing substances, including organic compounds like alcohols, often igniting them on contact due to exothermic oxidation. It is incompatible with flammable materials, metals, and acids, potentially causing fires or explosions. In aqueous environments, it dissolves readily to form chromic acid (H2CrO4), exhibiting deliquescent behavior and generating strongly acidic, corrosive solutions. Dry CrO3 remains stable under ambient conditions but requires isolation from moisture and reductants to prevent unintended reactions.

Synthesis and production

Industrial processes

The primary industrial method for producing chromium trioxide involves the reaction of with in an aqueous medium. In this process, (Na₂Cr₂O₇) is typically dissolved in to form a solution, to which concentrated (H₂SO₄) is added in a molar ratio of approximately 1:2.4 to 2.8 relative to the dichromate. The reaction proceeds as follows: Na₂Cr₂O₇ + 2 H₂SO₄ → 2 CrO₃ + + 2 , yielding chromium trioxide crystals alongside sodium sulfate and water. Following the acidification, the reaction mixture is evaporated to concentrate the liquor and induce of chromium trioxide, which precipitates due to its low in the acidic medium. The resulting is then subjected to solid-liquid separation via , with the collected crystals washed to remove impurities such as residual and dried to obtain the final product. This method allows for the production of high-purity chromium trioxide suitable for industrial applications, with process optimizations focusing on acid ratios and conditions to minimize side products and enhance . Variations of this process may employ potassium dichromate instead of sodium dichromate, though sodium salts are more common due to cost and availability from upstream chromate production. The feedstock sodium dichromate is itself derived from the roasting of chromite ore (FeCr₂O₄) with sodium carbonate, followed by extraction and acidification steps, but the final conversion to CrO₃ occurs via the described sulfuric acid treatment. Industrial-scale operations emphasize closed systems to manage the highly corrosive and oxidizing nature of the reagents, with evaporation often conducted under vacuum to reduce energy consumption and decomposition risks. Yields typically exceed 90% based on chromium content, though exact figures depend on purification efficiency.

Laboratory methods

A primary laboratory method for synthesizing chromium trioxide involves the acidification of an of with concentrated , which induces the of CrO₃ as dark red-purple crystals. In a typical procedure, 100 g of Na₂Cr₂O₇ is dissolved in 250 mL of , the solution is filtered to remove impurities, and then 200 mL of concentrated H₂SO₄ is added dropwise with constant stirring while maintaining a below 30°C to control the and promote selective . The addition continues until a slight permanent precipitate forms, indicating ; the mixture is then cooled to 0–5°C to maximize yield, yielding approximately 70–80 g of crude CrO₃ after . The precipitated chromium trioxide is washed with cold water or dilute to remove impurities and dried under or at low temperature (below 100°C) to prevent , as CrO₃ begins to lose oxygen above 150–180°C, forming Cr₂O₃. The reaction proceeds via the shift in the dichromate-chromic acid system: Na₂Cr₂O₇ + 2 H₂SO₄ → 2 NaHSO₄ + 2 H₂CrO₄, followed by to 2 CrO₃ + H₂O under acidic conditions. This method produces material of sufficient purity for use as an oxidant, though analytical-grade CrO₃ may require recrystallization from or . Alternative laboratory routes include the hydrolysis of (CrO₂Cl₂) with water, which yields that dehydrates to CrO₃ upon concentration, but this is less common due to the and of chromyl chloride. Small-scale preparations may also involve oxidizing chromium(III) salts with or under acidic conditions to form dichromate intermediates, followed by the acidification step, though yields are lower (typically 50–60%) and purification is more involved. These methods emphasize anhydrous conditions post-precipitation to avoid to H₂CrO₄, which is hygroscopic and less stable.

Applications

Industrial applications

Chromium trioxide serves as the primary source of hexavalent chromium in industrial electroplating processes, where it is converted to chromic acid by dissolution in sulfuric acid to form the electrolyte bath for depositing chromium coatings on metals. These coatings provide corrosion resistance, hardness, and low friction, with decorative plating typically applying thin layers (0.25–0.75 micrometers) for automotive trim, appliances, and consumer goods, while functional or hard chrome plating deposits thicker layers (up to 500 micrometers or more) for wear-resistant applications in hydraulic components, dies, molds, and aerospace parts. In aluminum , chromium trioxide is used in electrolytic baths to seal and harden layers, enhancing surface durability and resistance to environmental degradation in architectural panels, components, and equipment. It also facilitates copper stripping in manufacturing by oxidizing and dissolving layers selectively. Further industrial roles include formulation of inhibitors for fluids and as a catalyst or intermediate in producing pigments such as and lead chromate, though production volumes for pigments have declined due to toxicity concerns. Despite regulatory restrictions under frameworks like REACH and TSCA, authorized uses persist in at facilities employing closed-loop systems to minimize emissions, with global production historically exceeding 10,000 metric tons annually for these applications prior to 2010s phase-outs in non-essential sectors.

Laboratory and analytical uses

Chromium trioxide is employed in laboratory primarily as the active component in the Jones reagent, a formed by dissolving it in aqueous and diluting with acetone, which facilitates the selective oxidation of primary alcohols to carboxylic acids and secondary alcohols to ketones at . This reagent operates via formation , enabling efficient oxidation without affecting acid-sensitive groups like epoxides or acetals, and typically requires 2-3 equivalents of chromium trioxide per alcohol substrate for complete conversion. The method, introduced in 1962, remains a standard for preparative-scale oxidations due to its simplicity and high yields, often exceeding 90% for unhindered alcohols. In addition to synthetic applications, chromium trioxide-based mixtures are utilized for cleaning , leveraging their potent oxidizing action to dissolve and remove persistent organic contaminants, such as oils and residues, that resist milder detergents. These solutions, prepared by adding chromium trioxide to concentrated , achieve thorough decontamination but require careful handling and neutralization due to their corrosivity. Analytical uses of chromium trioxide are more limited but include its role as a in certain oxidative procedures for qualitative and quantitative determination of organic compounds, particularly in older protocols for or as a precursor to chromate standards in spectrophotometric assays. Its high purity grades, meeting ACS specifications with impurities below 0.01%, support reproducible results in such contexts.

Reactions

Fundamental chemical reactions

Chromium trioxide reacts exothermically with to form , a key intermediate in many of its applications:
CrO₃ + H₂O → H₂CrO₄. This reaction underscores its role as a source of the H₂CrO₄ species, which is itself a strong acid and oxidizer.
As a powerful oxidizing agent, chromium trioxide facilitates the oxidation of primary alcohols to carboxylic acids and secondary alcohols to ketones under acidic conditions, typically in the presence of sulfuric acid (as in the Jones reagent). For primary alcohols, the general transformation is RCH₂OH → RCOOH, while secondary alcohols yield R₂C=O; these reactions involve chromium reduction from +6 to +3 states. It also oxidizes aldehydes to carboxylic acids: RCHO → RCOOH. Upon heating above approximately 250 °C, chromium trioxide undergoes thermal decomposition, yielding lower-valent chromium oxides such as chromium(III) oxide (Cr₂O₃) and molecular oxygen, with intermediate species like CrO₂ possible depending on conditions. This process is exothermic and can pose explosion risks if confined. Chromium trioxide further reacts violently with reducing agents, including organic compounds and combustibles, often igniting or exploding due to rapid oxygen release.

Oxidation mechanisms

Chromium trioxide (CrO₃) functions as a potent primarily through its conversion to (H₂CrO₄) in aqueous acidic media, enabling the oxidation of alcohols via chromate ester intermediates. The overall process reduces Cr(VI) to Cr(III), typically involving a net two-electron transfer per carbonyl formation, though transient one-electron steps may occur with the formation of Cr(V) or Cr(IV) species. For secondary alcohols, the mechanism begins with nucleophilic attack by the alcohol oxygen on the electrophilic center of H₂CrO₄, displacing to form a chromate ester. This ester activates the alpha-hydrogen for by a (often or in the medium), leading to an E2-like elimination where the C-H bond cleaves concurrently with departure of the reduced species (as HCrO₃⁻ or similar), yielding the and regenerating the oxidant indirectly through subsequent cycles. The acidic conditions prevent reversal by protonating the carbonyl product, driving selectivity toward s without over-oxidation. Primary alcohols follow an analogous initial esterification and elimination to form aldehydes, but in protic solvents like water, the aldehyde hydrates to a gem-diol, which undergoes further formation and oxidation to the . This stepwise process requires two equivalents of oxidant per molecule, with the gem-diol mimicking a secondary in reactivity. In the variant (CrO₃ in aqueous H₂SO₄/acetone), acetone stabilizes the system by forming a less reactive chromic acid-acetone complex, minimizing side reactions while maintaining efficiency; reaction times are typically 5–30 minutes at 0–25°C for complete conversion. Beyond alcohols, CrO₃-mediated oxidations of other substrates, such as allylic or benzylic positions, proceed via similar or pathways under controlled conditions, though less commonly employed due to competing like SeO₂. The mechanism's reliance on acidic media underscores CrO₃'s incompatibility with acid-sensitive groups, limiting its scope compared to milder alternatives.

Hazards and toxicology

Human health effects

Chromium trioxide, as a soluble (Cr(VI)) compound, exerts acute toxic effects primarily through and dermal exposure, causing severe irritation to the including coughing, wheezing, and . In occupational settings with high airborne concentrations, such as plants, leads to marked damage to the and of the , often termed "chrome holes." Dermal contact results in corrosive burns, chrome ulcers (painless skin perforations), and , while ocular exposure causes severe and corneal damage. Ingestion of chromium trioxide is caustic to gastrointestinal mucosa, potentially leading to hemorrhagic , , , and renal failure; lethal doses range from 1 to 15 grams in adults. Chronic inhalation to chromium trioxide and other Cr(VI) compounds is associated with increased incidence of , as well as nasal and sinus cancers, with risk escalating in proportion to cumulative dose and duration; epidemiological studies in chromate workers report standardized mortality ratios for exceeding 2-10 times background rates. The International Agency for Research on Cancer classifies inhaled Cr(VI) compounds, including chromium trioxide, as carcinogenic to humans (), based on sufficient evidence from human and animal studies demonstrating genotoxic mechanisms such as formation after intracellular reduction to Cr(III). Limited human data suggest potential , including reduced fertility and developmental effects, though these are not conclusively established for chromium trioxide specifically and may derive from higher Cr(VI) exposures. Hematological effects like and immunological alterations, such as increased susceptibility, have been observed in chronically exposed workers, but causality remains linked to overall Cr(VI) burden rather than chromium trioxide alone. No-observed-adverse-effect levels for non-cancer effects are not well-defined due to variability in exposure metrics, but occupational permissible exposure limits for CrO3 are set at 0.1 mg/m³ (ceiling) to mitigate risks.

Exposure routes and mechanisms

Chromium trioxide, a compound (Cr(VI)), primarily enters the through , dermal contact, and , with being the dominant route in occupational settings due to dust or generation during handling, , or processing. occurs when fine particles or mists are , allowing rapid deposition in the , where Cr(VI) is readily absorbed across the lung via passive or anion mechanisms, owing to its high and ability to mimic anions. Dermal exposure arises from direct skin contact with solid CrO3, solutions, or contaminated surfaces, leading to through intact , particularly in scenarios involving prolonged or repeated contact without protective barriers. Cr(VI) penetrates the via diffusion, facilitated by its ionic nature and solubility, and can be reduced extracellularly or enter cells through / transporters, though absorption efficiency varies with skin integrity and compound form—higher for soluble Cr(VI) like derived from CrO3. Ingestion exposure is less common, typically accidental via contaminated hands, , or , but CrO3's high allows some gastrointestinal uptake, estimated at 2–9% for water-soluble Cr(VI) forms, primarily in the through similar anion transport pathways before intracellular to less mobile Cr(III). Overall, Cr(VI) absorption across routes depends on its state, with rapid intracellular generating and contributing to systemic distribution, though and exposures pose higher risks due to localized damage prior to clearance.

Environmental and regulatory aspects

Ecological impacts

Chromium trioxide (CrO3) dissociates in water to form chromic acid, releasing highly soluble and mobile hexavalent chromium (Cr(VI)) ions that persist in the environment due to slow reduction kinetics under neutral conditions. This speciation contributes to widespread ecological contamination from industrial effluents, such as chrome plating wastewater, leading to elevated Cr(VI) levels in surface waters and soils near facilities. Cr(VI) exhibits greater bioavailability and toxicity than trivalent chromium (Cr(III)), with reduction to the less toxic Cr(III) occurring primarily in anaerobic sediments or via microbial activity, though re-oxidation can occur in oxidized soils. In aquatic ecosystems, Cr(VI) poses acute and chronic risks to freshwater organisms at low concentrations, with U.S. EPA criteria recommending a final acute value of 21.2 μg/L and chronic value of 0.29 μg/L to protect biota. Toxicity manifests as mortality, gill hyperplasia, reduced growth, and impaired reproduction; for instance, Daphnia magna experiences reproduction inhibition at 10 μg/L, while Chinook salmon show DNA damage at 24 μg/L. Fish species like rainbow trout and Labeo rohita exhibit 96-hour LC50 values ranging from 39 to 120 mg/L, with sublethal effects including liver glycogen depletion, immune suppression, and genotoxicity via DNA strand breaks. In saltwater, criteria are higher (acute 1,260 μg/L, chronic 17.5 μg/L), but bioconcentration factors of 125–200 enable trophic transfer, amplifying risks to predators. Algae and invertebrates face similar disruptions in photosynthesis and filtration rates. Terrestrial impacts arise from deposition or , where Cr(VI) inhibits microbial activity and , reducing , , and nutrient uptake in crops like pakchoi. EPA ecological screening levels (Eco-SSLs) for Cr(VI) in mammalian herbivores reach 1,400 mg/kg dry weight, based on endpoints like and NOAELs of 1.5–85.7 mg/kg body weight/day, though data gaps prevent derivation for and . , including voles and , experience and survival declines at LOAELs of 2.47–5,000 mg/kg/day. in food webs exacerbates genotoxic effects, with Cr(VI) persisting due to limited natural attenuation in contaminated sites.
EcosystemAcute Toxicity Threshold (μg/L or mg/kg)Chronic EffectsKey Species AffectedSource
Freshwater Aquatic21.2 μg/L (final acute value)Reproduction/growth inhibition at 0.29–10 μg/L, ,
Saltwater Aquatic1,260 μg/L (final acute value)Mortality/growth at 17.5–132 μg/LMysid shrimp, polychaetes
Soil (Mammalian Herbivores)N/A (Eco-SSL 1,400 mg/kg dw for Cr(VI))Growth/reproduction NOAEL 1.5–85.7 mg/kg bw/dayVoles

Global regulations and restrictions

Chromium trioxide, a hexavalent chromium compound, faces extensive regulatory scrutiny globally due to its classification as a carcinogen and environmental hazard. In the European Union, it is included on the REACH Authorisation List (Annex XIV), mandating prior authorization from the European Chemicals Agency (ECHA) for any use after the sunset date of September 21, 2017, to ensure risks are adequately controlled. Authorizations have been granted to numerous companies for specific applications, such as functional chrome plating, with validity periods extending up to December 20, 2034 in some cases, subject to ongoing reviews and substitution efforts. In May 2025, ECHA proposed an EU-wide restriction on chromium trioxide and other Cr(VI) substances, prohibiting their use in mixtures above 0.01% except where worker exposure remains below defined occupational limits (e.g., 0.1 µg/m³ for inhalation) and releases are minimized, aiming to prevent up to 17 tonnes of annual Cr(VI) emissions into the environment. This proposal, under public consultation as of June 2025, targets remaining unauthorized or post-authorization uses, reflecting a shift toward broader phase-out despite industry reliance on the substance for corrosion resistance. In the United States, the Environmental Protection Agency (EPA) enforces National Emission Standards for Hazardous Air Pollutants (NESHAP) under 40 CFR Part 63, Subpart N, regulating emissions from operations, including limits such as 0.015 mg/dscm for small hard sources. The (OSHA) sets a (PEL) of 5 µg/m³ as an 8-hour time-weighted average for , including , with requirements for , , and medical surveillance. Additionally, the EPA restricts -based chemicals under 40 CFR § 749.68, prohibiting their use in certain cooling towers to mitigate discharge risks. These measures focus on emission controls and workplace safety rather than outright bans, allowing continued industrial application with compliance. Internationally, chromium trioxide is classified under the Globally Harmonized System (GHS) as acutely toxic, corrosive, mutagenic, carcinogenic, and , prompting communication requirements but no treaty-based . Restrictions in other jurisdictions, such as and , align with GHS and mirror EU/ exposure limits, though enforcement varies; for instance, no comprehensive global phase-out exists under frameworks like the Stockholm Convention, emphasizing national-level controls over transboundary trade. Ongoing trade actions, including a 2025 U.S. antidumping investigation on imports from and , indirectly influence supply but stem from economic rather than .

Economic and industrial debates

The authorization process under the EU's REACH regulation, initiated in for chromium trioxide as a due to its carcinogenic properties, has sparked significant industrial opposition, with companies arguing that the requirement for case-by-case approvals imposes excessive administrative and compliance burdens, potentially disrupting supply chains in sectors like and automotive . consortia submitted over 200 joint authorization applications by 2016 to maintain uses in and etching, emphasizing that alternatives often fail to replicate the corrosion resistance and hardness of coatings, which are critical for components such as aircraft and hydraulic pistons. Economic analyses highlight the high costs of , with trivalent chromium processes requiring substantial investments in modifications—estimated at €10-50 million per —and yielding inferior in demanding applications, leading to projected annual losses of €100-500 million for EU platers if unrestricted phase-out occurs. Proponents of continued use, including manufacturers, contend that the socio-economic benefits, such as preserved jobs (over 50,000 in EU alone) and maintained competitiveness against non-EU producers without similar restrictions, outweigh mitigated health risks when exposure controls are implemented, as evidenced by declining worker exposure levels post-authorization. Critics, however, point to court rulings like Case C-144/21 in 2024, which invalidated some authorizations for inadequate analysis of available alternatives, underscoring debates over the stringency of risk assessments versus practical industrial feasibility. Ongoing 2025 proposals for broader REACH restrictions on chromium trioxide and related Cr(VI) compounds have intensified discussions, with ECHA's socio-economic evaluations estimating societal costs of compliance or at €314 million to €3.23 billion, including R&D for nanostructured or PVD alternatives that remain unproven at scale for hard applications. Globally, U.S. producers' 2025 trade actions against dumped imports from and reflect parallel concerns over unfair competition, as unrestricted production elsewhere undercuts efforts to innovate safer processes without economic penalties. These debates underscore a tension between regulatory drives for and evidence that no equivalent fully matches trioxide's technical efficacy without trade-offs in cost, , or .